UMike
Klutzing in Re-Thai-erment
- Joined
- 16 January 2007
- Posts
- 1,663
- Reactions
- 2,125
Good to see they're continuing to get their receiveables in order. They used to pretty much fund all their customers. I think it's probably still too early to get too excited though, especially with more PBS price changes coming.
Thanks pixel,
I've made and lost more money on SIP and it's monster father SIG than I care to count.
I'll keep an eye on it.
Chart looks promising.
gg
what have we here...I like the new restructure and balance sheet much much better than the old SIP..never own the old SIP....
decent dividend and prospect of maintain and increase dividend is high that seal the deal....and I like management proactively exercise their capital allocation by buying back shares when it's nice and cheap...short term cash drain for massive long term gain....
just as simple as that no need for fancy formula
when I like something I like to buy... I hop on board not long ago.
sit back and sip coffee and enjoy dividend twice a year
Pharmaceutical distribution, especially the generic products, might be one of those markets where the margins are so low that the existing distribution channels and contractual/compliance channels of incumbents such as SIP provide a sufficient defensive moat. With the massive destruction of shareholder value that occurred in the GFC I've never looked into SIP but it could be a defensive income earner?
The new management is very focus and know where to target high margin area...it may not show up for a few years but happy to collect 6% dividend while I wait and I can almost be certain dividend can be maintained
There is more to the new SIP than just generic drugs, buy the time the market see it
it's doing a bunnings......
The new management is very focus and know where to target high margin area...it may not show up for a few years but happy to collect 6% dividend while I wait and I can almost be certain dividend can be maintained
SIP is due to report this Thursday. I'll be interested to read the report. Just a question - what is preventing Woolworths or Wesfarmers from entering the pharmacy market? I seem to recall that there is some regulatory ban against them contesting this market?
Share price is sitting on a very long term support level at 62c.
Alan Mitchell wrote about the issue about 12 months ago, urging Julia Gillard to change the laws, but of course nothing happened (http://www.afr.com/p/opinion/prescription_for_savings_4DSByEpIww0fJWpL0sXPHM), and given that Abbott apparently pledged his support for the industry prior to the election, still nothing will happen (http://www.pharmacynews.com.au/news/latest-news/coalition-s-letters-of-support-reassure-guild). Like the ridiculous prices Australians have to pay for software, it looks like Australians will have to pay ridiculous prices for drugs, unless the drugs are subsidised on the PBS (which as its own issues, as Brian Toohey never tires of pointing out, though it seems nobody listens to him).
It seems that SIP is bucking the trend after today nudging 80c, despite being in a business which is similarly affected by GP flow-on volumes of clients.
I think the impact of the GP co-payments is being a tad exaggerated - both by the public, and by the investment community. But that's perhaps for another thread.
SIP going from strenght to strenght with the latest aquisition
I foreshadow this a while ago when I bought this baby cheap, and by the time the market see what is going on with SIP it already bolt ... time to grow again
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?